Allstate Corp (NYSE:ALL) Director Judith A. Sprieser sold 2,225 shares of the business’s stock in a transaction on Friday, June 21st. The stock was sold at an average price of $102.63, for a total transaction of $228,351.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
NYSE:ALL traded up $0.26 during mid-day trading on Thursday, reaching $103.20. The stock had a trading volume of 1,205,920 shares, compared to its average volume of 1,922,373. The company has a market capitalization of $34.91 billion, a PE ratio of 12.79, a P/E/G ratio of 1.41 and a beta of 0.81. The company has a 50 day moving average price of $101.40. Allstate Corp has a one year low of $77.00 and a one year high of $107.43. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.30.
Allstate (NYSE:ALL) last posted its earnings results on Wednesday, May 1st. The insurance provider reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.28 by $0.02. Allstate had a return on equity of 12.66% and a net margin of 6.26%. The company had revenue of $8.70 billion for the quarter, compared to the consensus estimate of $8.82 billion. During the same quarter in the prior year, the company earned $2.96 earnings per share. Allstate’s revenue was up 6.9% on a year-over-year basis. Equities research analysts anticipate that Allstate Corp will post 8.9 earnings per share for the current year.
Several equities research analysts recently weighed in on the stock. UBS Group reiterated a “buy” rating and set a $25.00 price objective on shares of Infineon Technologies in a research note on Tuesday, May 7th. Credit Suisse Group began coverage on shares of Merck & Co., Inc. in a report on Thursday, July 11th. They issued a “buy” rating and a $95.00 price objective for the company. Barclays restated a “buy” rating and issued a $65.00 price target on shares of Owens Corning in a research report on Monday, July 1st. Zacks Investment Research downgraded shares of KKR & Co Inc from a “buy” rating to a “hold” rating in a research report on Friday, March 22nd. Finally, Goldman Sachs Group upgraded shares of Koninklijke KPN from a “neutral” rating to a “buy” rating in a research report on Wednesday, May 29th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $103.46.
Several hedge funds and other institutional investors have recently made changes to their positions in ALL. Norges Bank acquired a new position in Allstate in the 4th quarter valued at $189,048,000. Boston Partners grew its stake in Allstate by 17.1% in the first quarter. Boston Partners now owns 11,106,016 shares of the insurance provider’s stock worth $1,045,965,000 after purchasing an additional 1,620,871 shares during the period. Macquarie Group Ltd. grew its stake in Allstate by 6.3% in the fourth quarter. Macquarie Group Ltd. now owns 7,852,608 shares of the insurance provider’s stock worth $648,861,000 after purchasing an additional 468,725 shares during the period. Geode Capital Management LLC grew its stake in Allstate by 9.0% in the fourth quarter. Geode Capital Management LLC now owns 4,733,322 shares of the insurance provider’s stock worth $390,468,000 after purchasing an additional 391,869 shares during the period. Finally, Atalanta Sosnoff Capital LLC purchased a new stake in Allstate in the second quarter worth $39,602,000. 77.40% of the stock is owned by institutional investors.
Allstate Company Profile
The Allstate Corporation, through its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection, Service Businesses, Allstate Life, and Allstate Benefits segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home insurance; and commercial lines products under the Allstate, Esurance, and Encompass brand names.
Recommended Story: Investing in Growth Stocks
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.